Fulcrum Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Fulcrum Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025

Transcript

Q2 2025

Jul 29, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 1, 2025

Transcript

Quarterly report10-Q

Earnings release8-K

Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Feb 25, 2025

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 13, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Jul 31, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 13, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 27, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 7, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 3, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 15, 2023

Quarterly report10-Q

Earnings release8-K

JPMorgan Healthcare Conference

Jan 12, 2023

Slides

2022

Q4 2022

Mar 9, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 8, 2022

Quarterly report10-Q

Earnings release8-K

2021

Q4 2021

Mar 3, 2022

Annual report10-K

2020

Q4 2020

Mar 4, 2021

Annual report10-K

2019

Q4 2019

Mar 5, 2020

Annual report10-K